Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases. Fares J, Petrosyan E, Kanojia D, Dmello C, et al. J Clin Invest 2023;133:e161142.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fares J, Petrosyan E, Kanojia D, Dmello C, et al. Metixene is an incomplete autophagy inducer in preclinical models of metastatic cancer and brain metastases. J Clin Invest 2023;133:e161142.
PMID: 37847564